3.11
急性呼吸不全は、肺の主な機能であるガス交換を行えない状態を特徴とする疾患です。この疾患により、血液中の酸素濃度が不十分 (低酸素血症) になったり、二酸化炭素濃度が上昇 (高炭酸ガス血症) したり、あるいはその両方が生じ、臓器機能に重大な障害が生じます。
定義: 血液ガス測定に基づく特定の基準によっ…
急性呼吸不全は、呼吸器系が体の酸素化、換気、または代謝の必要量を満たさない場合に発症します。
これは、有毒な吸入などの肺の状態や、ショックなどの全身の問題に起因する可能性があります。
急性呼吸不全は、低酸素血症、PaO2の60ミリメートル水銀柱未満への減少、および高炭酸ガス血症、動脈PaCO2の45ミリメートル水銀柱への増加、および動脈pHが7.35未満のアシドーシスを伴います。
呼吸不全のカテゴリーには、以下のものがあります:
低酸素症性呼吸不全または酸素化不全は、肺胞から肺毛細血管への酸素移動が不十分な場合に発生します。
これは、水銀柱の60ミリメートル未満のPaO2と、吸気酸素濃度が60%以上で識別されます。
高炭酸ガス血症の呼吸不全または人工呼吸器障害は、体が二酸化炭素を適切に除去できない場合に発生します。
これは、45ミリメートルの水銀と動脈pHが7.35未満の酸性血症のPaCO2によって特徴付けられます。
View the full transcript and gain access to JoVE Core videos
Q1: What defines acute respiratory failure in terms of blood gas measurements?
Acute respiratory failure is defined by specific arterial blood gas criteria: hypoxemia with PaO2 below 60 millimeters of mercury and hypercapnia with PaCO2 above 45 millimeters of mercury, accompanied by acidosis with arterial pH below 7.35. These changes occur suddenly and are severe enough to necessitate immediate intervention.
Q2: How does hypoxemic respiratory failure differ from hypercapnic respiratory failure?
Hypoxemic respiratory failure occurs when oxygen transfer from alveoli to pulmonary capillaries is insufficient, identified by PaO2 less than 60 millimeters of mercury despite inspired oxygen concentration of 60 percent or higher. Hypercapnic respiratory failure results from inadequate carbon dioxide removal, characterized by PaCO2 over 45 millimeters of mercury and acidemia with pH below 7.35.
Q3: What causes hypoxemic respiratory failure in the lungs?
Hypoxemic respiratory failure results from conditions that impair the lungs' ability to oxygenate blood, such as pneumonia, acute respiratory distress syndrome, pulmonary edema, or lung injuries. These conditions prevent sufficient oxygen transfer between the alveoli and pulmonary capillaries, leading to low blood oxygen levels without necessarily elevated carbon dioxide.
Q4: What respiratory and neurological conditions lead to hypercapnic respiratory failure?
Hypercapnic respiratory failure develops from conditions affecting respiratory mechanics or neural control of breathing, including neuromuscular disorders, spinal cord injuries, severe chronic obstructive pulmonary disease exacerbations, and airway obstruction. These conditions impair the body's ability to adequately remove carbon dioxide, resulting in elevated PaCO2 and acidemia.
Q5: How do systemic circulatory problems contribute to acute respiratory failure?
Circulatory conditions like shock or severe heart failure reduce oxygenated blood delivery to body tissues, contributing to acute respiratory failure through impaired oxygen delivery. Although the lungs may function normally, systemic oxygen delivery fails to meet metabolic requirements, resulting in tissue hypoxemia and respiratory compromise.
Q6: What risk factors increase susceptibility to acute respiratory failure?
Risk factors include smoking, which damages lung tissue and leads to chronic obstructive pulmonary disease; chronic lung diseases like asthma; immunosuppression increasing infection susceptibility; chronic heart conditions affecting lung oxygenation; and chest trauma impairing breathing or lung function. These factors compromise respiratory system function and increase failure risk.
Q7: Why is understanding the type of respiratory failure important for patient treatment?
Understanding whether acute respiratory failure is hypoxemic or hypercapnic is crucial for providing appropriate treatment and improving patient outcomes. The underlying cause and failure type determine specific interventions: hypoxemic failure requires oxygenation support, while hypercapnic failure requires ventilatory assistance and management of the primary cause.